Healthy volunteers test two pill strengths for future cancer drug
NCT ID NCT05390944
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 25 times
Summary
This study tested whether a 10 mg and a 20 mg capsule of the experimental drug IMP4297 are processed similarly by the body. It involved 28 healthy Chinese adults who took a single dose of each strength on separate days. The goal was to check bioequivalence, not to treat any disease. No direct health benefits were expected for participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xuzhou Central Hospital
Xuzhou, Jiangsu, 221000, China
Conditions
Explore the condition pages connected to this study.